Robert van der Put has over 20 years of experience in the vaccine industry. He is a passionate and driven Director of Business Development at Intravacc, a leading institute for translational vaccinology. His mission is to advance the development and production of safe and effective vaccines for global health, by leveraging his expertise in conjugate vaccine development, process optimization, quality control, and technology transfer. He has successfully facilitated the technology transfer of a Hib conjugate vaccine production process to several partners in Asia, and designed and delivered an international course on Hib conjugate QC tests in collaboration with WHO.
Furthermore, he also contributed to the innovation and improvement of various vaccine production processes, such as Polio, N. meningitidis, Shigella flexneri 2a, and COVID-19. He has published multiple scientific papers and presented at several international conferences and workshops on vaccine-related topics. He is always eager to learn new skills, collaborate with diverse stakeholders, and create value for the vaccine community.